Antiplatelet agent in hospital type

General Details:

Name:
Antiplatelet agent in hospital type
Steward:
NINDS
Definition:
Type(s) of antiplatelet agents received during the acute hospital stay
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Aspirin Aspirin Aspirin
Aspirin/Dipyridamole (in separate formulations or as Aggrenox) Aspirin/Dipyridamole (in separate formulations or as Aggrenox) Aspirin/Dipyridamole (in separate formulations or as Aggrenox)
Clopidogrel (Plavix) Clopidogrel (Plavix) Clopidogrel (Plavix)
Other, specify Other, specify Other, specify
Cilostazol Cilostazol Cilostazol

Designations:

Designation:
Antiplatelet agent in hospital type
Tags:

Designations:

Definition:
Type(s) of antiplatelet agents received during the acute hospital stay
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry<br /><br />Barnes GD, Ageno W, Ansell J, Kaatz S; Subcommittee on the Control of Anticoagulation of the International Society on Thrombosis and Haemostasis. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH [published correction appears in J Thromb Haemost. 2015;13(8):1539]. J Thromb Haemost. 2015;13(6):1154-1156.<br /><br />Kim BJ, Kwon SU, Park JH, Kim YJ, Hong KS, Wong LKS, Yu S, Hwang YH, Lee JS, Lee J, Rha JH, Heo SH, Ahn SH, Seo WK, Park JM, Lee JH, Kwon JH, Sohn SI, Jung JM, Navarro JC, Kim HY, Kim EG, Kim S, Cha JK, Park MS, Nam HS, Kang DW; PICASSO Investigators. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial. Stroke. 2020 Mar;51(3):931-937.

Identifiers:

Source:
NLM
Id:
HXVHcdJ5uCr
Version:
3.1
Source:
BRICS Variable Name
Id:
AntiplatAgentInHospTyp
Version:
Source:
NINDS
Id:
C14632
Version:
3